Trial intelligence / Profile preview

Compound betamethasone + ropivacaine vs ropivacaine alone for erector spinae plane block after thoracoscopic surgery

ChiCTR2400087781Phase 4Recruiting

Sponsor
Yan'an Affiliated Hospital of Kunming Medical University
Start
Aug 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in postoperative pain and postoperative nausea and vomiting (PONV) comparing Compound betamethasone + ropivacaine ESPB with Ropivacaine alone ESPB (2 arms). Primary endpoints: Incidence of moderate to severe pain within 24 hours after surgery and Postoperative quality of recovery. Started Aug 2024; status: recruiting.

02

Drugs

betamethasoneropivacaine
03

Conditions

postoperative painpostoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on ChiCTR2400087781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400087781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call